Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01DK125786-02
Deferoxamine for the Prevention of Acute Kidney Injury
National Institutes of Health
Grant: 1R01DK130839-01
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
National Institutes of Health
Grant: 5R01HL144566-04
Precision Medicine Approach to Vitamin D3 Administration in Critical Illness
National Institutes of Health
Grant: 5R01DK126685-02
Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney Injury
National Institutes of Health
Grant: 1K23DK125672-01A1
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury
Fields of Study
Keywords
Sustainable Development Goals